scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPREGU.1998.274.1.R23 |
P698 | PubMed publication ID | 9458894 |
P2093 | author name string | Wellman PJ | |
McMahon LR | |||
P433 | issue | 1 Pt 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | R23-9 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | American Journal of Physiology | Q2160146 |
P1476 | title | PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats | |
P478 | volume | 274 |
Q47736265 | A Vitamin B12 Conjugate of Exendin-4 Improves Glucose Tolerance Without Associated Nausea or Hypophagia in Rodents. |
Q30352488 | Activation of murine pre-proglucagon-producing neurons reduces food intake and body weight. |
Q36807579 | Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake |
Q36718656 | Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance. |
Q37174896 | CNS GLP-1 regulation of peripheral glucose homeostasis |
Q44516249 | CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. |
Q36796571 | Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation |
Q39146023 | Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides |
Q36979763 | Central control of body weight and appetite |
Q36953564 | Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis |
Q39419249 | Characterizing ingestive behavior through licking microstructure: Underlying neurobiology and its use in the study of obesity in animal models |
Q88924595 | Endocannabinoids in Body Weight Control |
Q39249139 | Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control |
Q45070671 | Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus |
Q35948898 | Exendin-4 decreases amphetamine-induced locomotor activity |
Q41449397 | Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats |
Q34745109 | Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. |
Q36474058 | Feeding and the rhodopsin family g-protein coupled receptors in nematodes and arthropods |
Q37885717 | GLP-1 and energy balance: an integrated model of short-term and long-term control |
Q38794234 | GLP-1 and weight loss: unraveling the diverse neural circuitry |
Q35200252 | GLP-1 based therapeutics: simultaneously combating T2DM and obesity. |
Q35744558 | GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake |
Q27000749 | GLP-1, the gut-brain, and brain-periphery axes |
Q90016044 | GLP-1: Molecular mechanisms and outcomes of a complex signaling system |
Q48325811 | Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons |
Q41816012 | Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed |
Q35893496 | Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake |
Q37224352 | Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats. |
Q35601526 | Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake |
Q33911780 | Glucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats |
Q36452530 | Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism |
Q37054716 | High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats. |
Q37142459 | Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt. |
Q33901243 | Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats |
Q35647295 | Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission |
Q38629710 | Hippocampus Contributions to Food Intake Control: Mnemonic, Neuroanatomical, and Endocrine Mechanisms |
Q37892968 | Hypothalamic control of energy and glucose metabolism |
Q35690970 | Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose |
Q35024826 | Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation |
Q88732200 | Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons |
Q28072517 | Microbial regulation of GLP-1 and L-cell biology |
Q37244738 | Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. |
Q26826926 | Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward |
Q38197775 | Neural integration of satiation and food reward: role of GLP-1 and orexin pathways. |
Q36339320 | PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation. |
Q40443483 | Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia |
Q35110843 | Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. |
Q48344210 | Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia. |
Q36955246 | Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice |
Q37219033 | Pharmacologically Counteracting a Phenotypic Difference in Cerebellar GABAA Receptor Response to Alcohol Prevents Excessive Alcohol Consumption in a High Alcohol-Consuming Rodent Genotype |
Q59812434 | Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function |
Q37139700 | Role of lateral septum glucagon-like peptide 1 receptors in food intake |
Q34425122 | Role of oxytocin signaling in the regulation of body weight |
Q42737933 | Satiation and stress-induced hypophagia: examining the role of hindbrain neurons expressing prolactin-releasing Peptide or glucagon-like Peptide 1. |
Q36469127 | Sex and estrogens alter the action of glucagon-like peptide-1 on reward |
Q93367537 | The Functional and Neurobiological Properties of Bad Taste |
Q38850561 | The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight |
Q26799942 | The L-Cell in Nutritional Sensing and the Regulation of Appetite |
Q28484398 | The anorectic effect of GLP-1 in rats is nutrient dependent |
Q30596646 | The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss |
Q21129358 | The central GLP-1: implications for food and drug reward |
Q28216072 | The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness |
Q37343491 | The effects of GLP-1 infusion in the hepatic portal region on food intake |
Q47996706 | The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. |
Q35035127 | The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice |
Q28534678 | The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice |
Q28598004 | The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents |
Q34621785 | The gut and food intake: an update for surgeons. |
Q41718186 | The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. |
Search more.